Tag Archives: medical affairs

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Within the pharmaceutical sector, medical information groups shoulder great responsibilities. The principal role of medical information groups, which are typically part of the medical affairs organization, is responding to questions about products from external groups such as physicians. While this

Achieving Better Advocacy Group Relationships a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry

When it comes to informing physicians and patients about new therapies, disease awareness programs have experienced a rebirth in the pharmaceutical industry. For decades, disease awareness campaigns were a part of the playbook for educating physicians and patients about new

Pharma Executive Talks Timing, Targeting and Trouble for Disease State Awareness Campaigns

In the pharmaceutical sector, disease state awareness campaigns are one of the few ways to reach patients and physicians before a product is approved. In essence, they set the table for future marketing efforts at product launch and post-launch. While

5 Important Trends Shaping Pharma Business in 2016

In a sector as fast-changing as biopharmaceuticals, it’s important to look beyond today’s hot topics to identify the long-term factors which are really driving change in the industry. From a list that could include a hundred headline-grabbing trends, we’ve pinned

Creating and Maintaining a Strategic KOL Management and Engagement System

Across the pharmaceutical sector, regulatory and access issues have reshaped interactions with Key Opinion Leaders (KOLs). And with KOL interactions affecting everything from clinical development to product launch, the issue of strategically managing these critical exchanges looms large for small

Role of Medical Affairs Increasing in Oncology Launch

The Medical Affairs function plays a vital role in a host of oncology activities, including identification and engagement of Key Thought Leaders to guidance of commercial strategies and launch resources management. It is becoming increasingly apparent that a successful launch

Best Practices Hosting 6th Medical Affairs Consortium on HEOR

Best Practices will be hosting the sixth roundtable of our Medical Affairs Consortium on Thursday (May 28th) from 11:00AM-12:30PM (EST) via a virtual roundtable to discuss “Medical Affairs’ Role in Health Economics & Outcomes Research.” This is the final roundtable

Exclusive: Key Findings from Best Practices’ 5th Medical Affairs Consortium

Best Practices recently completed the second roundtable of our 2014-2015 Medical Affairs Consortium. The roundtable addressed the topic of “Medical Affairs Launch Support.” The roundtable brought together executives from 13 leading pharmaceutical organizations. Some exclusive key findings from the discussion

Top Trends in 2015 – Is Your Organization Prepared?

2015 is here & with the New Year comes many new trends and topics of discussion. With the increasing importance of payers and high demand on evidence-based information, it is clear that there are many shifts happening in the pharmaceutical,

Medical Affairs Consortium: Impact Measures, Globalization & Compliance

On November 6, 2014 Best Practices, LLC hosted the 1st roundtable of the 2014-2015 Medical Affairs’ Consortium. The roundtable brought together leaders from: Baxter, Crescendo, Eli Lilly, Genentech, Incyte Corporation, Jazz Pharmaceuticals, Pfizer, Santen Inc., Teva, and Upsher-Smith. Leaders from

Best Practices’ Hosting Medical Affairs Consortium Roundtable Thursday, Nov. 6

Best Practices designed the Medical Affairs Consortium to provide Medical Affairs leaders with a forum for sharing insights about the key challenges they face. The consortium has developed a mechanism for creating and sharing solutions through three virtual roundtable discussions

SPECIAL: 2014-2015 Medical Affairs Consortium Survey Has Launched

As the healthcare landscape changes, the Medical Affairs function has begun to play increasingly important roles in clinical development, market education, and regulatory compliance. Now, more than ever, leaders can learn valuable lessons from their peers on how they overcome

Effectively & Efficiently Serving Thought Leaders

As this slide shows, Medical Affairs, Clinical Affairs and Marketing all have a hand in the management of Key Opinion Leaders (KOLs). Unfortunately, these functions are seldom bridged by processes, personnel or systems. When such work silos are created, you can be

Best Practices Kicks off 2014-2015 Medical Affairs Consortium

Medical Affairs functions have a significant influence on a healthcare company’s overall success. As the pharmaceutical, biotech, medical device, and health care technology markets become increasingly competitive and complex, it is crucial for leaders to understand how to best operate